Dec. 10, 2019 Price forecast | 2 weeks: -4.46% | 1 month: -9.28% | 3 months: -13.70%


ISEE stock forecast

Our latest prediction for IVERIC bio, Inc.'s stock price was made on the Dec. 10, 2019 when the stock price was at 5.41$.

In the short term (2weeks), ISEE's stock price should underperform the market by -4.46%. During that period the price should oscillate between -11.95% and +15.49%.

In the medium term (3months), ISEE's stock price should underperform the market by -13.70%. During that period the price should oscillate between -28.85% and +21.49%.


About IVERIC bio, Inc.

IVERIC bio, Inc. is a biopharmaceutical company which engages in discovering, developing, and commercializing novel therapeutics to treat ophthalmic diseases, with a focus on age-related and orphan retinal diseases. Its product candidates include Zimura and Gene Therapy. The company was founded by David R. Guyer and Samir Chandrakant Patel on January 5, 2007 and is headquartered in New York, NY.

At the moment the company generates 210M USD in revenues.

On its last earning announcement, the company reported a profit of 1.83$ per share.

The book value per share is 2.75$

IVERIC bio, Inc. website


Three months stock forecastDec. 10, 2019


Financials

Revenue USD Gross Margin Operating Income Operating Margin Net Income Earnings Per Share Dividends Payout Ratio Shares Book Value Per Share Operating Cash Flow Cap Spending Free Cash Flow
210M 100.00% -65M 51.40% 63M 1.83 - - 41M 2.75 -47M -1M -47M